LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

Kodu・Aktsiate loetelu・Glaukos Corp

Glaukos Corp

Suletud

SektorTervishoid

91.5 4.01

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

86.25

Max

92.11

Põhinäitajad
By Trading Economics
Sissetulek	3.4M -16M
Müük	9.4M 134M
Aktsiakasum	-0.16
Kasumimarginaal	-12.155
Töötajad	995
EBITDA	8.1M -570K

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+32.69% upside

Turustatistika
By TradingEconomics
Turukapital	734M 5.1B
Eelmine avamishind	87.49
Eelmine sulgemishind	91.5

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

87.61 / 93 Toetus ja vastupanu

Glaukos Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

18. nov 2025, 19:25 UTC

Omandamised, ülevõtmised, äriostud

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18. nov 2025, 18:09 UTC

Omandamised, ülevõtmised, äriostud

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18. nov 2025, 17:39 UTC

Omandamised, ülevõtmised, äriostud

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18. nov 2025, 16:25 UTC

Suurimad hinnamuutused turgudel

Diginex Rises on Deal With Digital Asset Platform Evident

18. nov 2025, 23:56 UTC

Market Talk

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18. nov 2025, 23:39 UTC

Market Talk

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18. nov 2025, 22:59 UTC

Market Talk

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18. nov 2025, 22:08 UTC

Market Talk

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18. nov 2025, 22:03 UTC

Omandamised, ülevõtmised, äriostud

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18. nov 2025, 22:03 UTC

Tulu

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18. nov 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

18. nov 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. nov 2025, 21:15 UTC

Market Talk

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18. nov 2025, 20:46 UTC

Market Talk

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18. nov 2025, 20:13 UTC

Market Talk

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18. nov 2025, 19:48 UTC

Market Talk

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18. nov 2025, 18:29 UTC

Tulu

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18. nov 2025, 18:18 UTC

Market Talk

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18. nov 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

18. nov 2025, 17:19 UTC

Market Talk

Tulu

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18. nov 2025, 17:06 UTC

Tulu

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18. nov 2025, 16:06 UTC

Omandamised, ülevõtmised, äriostud

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18. nov 2025, 15:59 UTC

Tulu

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18. nov 2025, 15:35 UTC

Omandamised, ülevõtmised, äriostud

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18. nov 2025, 15:35 UTC

Omandamised, ülevõtmised, äriostud

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Võrdlus sarnastega

Hinnamuutus

Glaukos Corp Prognoos

Hinnasiht

By TipRanks

32.69% tõus

12 kuu keskmine prognoos

Keskmine 117.3 USD 32.69%

Kõrge 165 USD

Madal 72 USD

Põhineb 12 Wall Streeti analüütiku instrumendi Glaukos Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

12 ratings

Osta

Hoia

Müü

Põhineb 12 analüütiku instrumendi Glaukos Corp aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

87.61 / 93Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Bearish events outweigh bullish events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.